Dr Reddy's announces launch of Sildenafil tablets

Pharma major Dr Reddy's Laboratories today announced that it has launched Sildenafil tablets, a bioequivalent generic version of Revatio (Sildenafil) tablets in the US market.

This followed the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy's ANDA for Sildenafil tablets, a company statement said here.

The Revatio brand had US sales of approximately $38.67 million for the most recent twelve months ending September 2012, according to IMS Health.

Dr Reddy's Sildenafil tablets in 20 mg are available in 90 count bottle sizes, the release said.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • The Constitution defines complimentary roles for executive and judiciary

    For avid constitutionalists, it is important to remember that while the executive and the judiciary constitute two major pillars of any democratic ord

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Urs Schöttli

Hong Kong’s democratic dilemma

The 19th and 20th centuries were very unkind to China. ...

Parvez Imam

Does a piece of paper define your identity?

Papers are not papers, after all! Just like you are ...

Bubbles Sabharwal

The importance of looking at the bright side

Now here’s the thing. When your body defies gravity, it ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture